sirolimus

Generic: sirolimus

Labeler: mylan pharmaceuticals inc.
NDC Directory HUMAN PRESCRIPTION DRUG NDA AUTHORIZED GENERIC Inactive Finished

Drug Facts

Product Profile

Brand Name sirolimus
Generic Name sirolimus
Labeler mylan pharmaceuticals inc.
Dosage Form TABLET, SUGAR COATED
Routes
ORAL
Active Ingredients

sirolimus 2 mg/1

Manufacturer
Mylan Pharmaceuticals Inc.

Identifiers & Regulatory

Product NDC 59762-1003
Product ID 59762-1003_d4ab5d7b-b3f2-41d8-bd06-e3a85695264e
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA AUTHORIZED GENERIC
Application Number NDA021110
Listing Expiration 2026-12-31
Marketing Start 2014-10-27

Pharmacologic Class

Established (EPC)
mtor inhibitor immunosuppressant [epc] kinase inhibitor [epc]
Mechanism of Action
mtor inhibitors [moa] protein kinase inhibitors [moa]
Physiologic Effect
decreased immunologic activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 597621003
Hyphenated Format 59762-1003

Supplemental Identifiers

RxCUI
349208 360110 905158
UNII
W36ZG6FT64
NUI
N0000175550 N0000175625 N0000175624 N0000175605 N0000175076

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name sirolimus (source: ndc)
Generic Name sirolimus (source: ndc)
Application Number NDA021110 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 2 mg/1
source: ndc
Packaging
  • 100 TABLET, SUGAR COATED in 1 BOTTLE (59762-1003-1)
source: ndc

Packages (1)

59762-1003-1 100 TABLET, SUGAR COATED in 1 BOTTLE (59762-1003-1)

Ingredients (1)

sirolimus (2 mg/1)

Linked Drug Pages (1)

Sirolimus ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "d4ab5d7b-b3f2-41d8-bd06-e3a85695264e", "openfda": {"nui": ["N0000175550", "N0000175625", "N0000175624", "N0000175605", "N0000175076"], "unii": ["W36ZG6FT64"], "rxcui": ["349208", "360110", "905158"], "spl_set_id": ["5908cd1a-fc5a-462f-99ed-1d8983e253c9"], "pharm_class_pe": ["Decreased Immunologic Activity [PE]"], "pharm_class_epc": ["mTOR Inhibitor Immunosuppressant [EPC]", "Kinase Inhibitor [EPC]"], "pharm_class_moa": ["mTOR Inhibitors [MoA]", "Protein Kinase Inhibitors [MoA]"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, SUGAR COATED in 1 BOTTLE (59762-1003-1)", "package_ndc": "59762-1003-1", "marketing_start_date": "20141027"}], "brand_name": "Sirolimus", "product_id": "59762-1003_d4ab5d7b-b3f2-41d8-bd06-e3a85695264e", "dosage_form": "TABLET, SUGAR COATED", "pharm_class": ["Decreased Immunologic Activity [PE]", "Kinase Inhibitor [EPC]", "Protein Kinase Inhibitors [MoA]", "mTOR Inhibitor Immunosuppressant [EPC]", "mTOR Inhibitors [MoA]"], "product_ndc": "59762-1003", "generic_name": "SIROLIMUS", "labeler_name": "Mylan Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Sirolimus", "active_ingredients": [{"name": "SIROLIMUS", "strength": "2 mg/1"}], "application_number": "NDA021110", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_start_date": "20141027", "listing_expiration_date": "20261231"}